While patients with acute myeloid leukemia (AML) are routinely treated with chemotherapy and other cell-killing therapies, ...

Guidelines recommend older adults with newly diagnosed AML should be offered antileukemic therapy over best supportive care.

A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute ...

Review of current and emerging treatments for older adults with acute myeloid leukemia, highlighting venetoclax plus ...

A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...

Leukemia and lymphoma are cancers that affect the blood or bone marrow. Fifteen percent of people with leukemia have chronic myeloid leukemia (CML), which has seen a 55% jump in new cases over the ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...

Continues to drive enrollment with increase to 78% now consentedBlinded response activity tracking within expected rangeConsented subjects now ...

RMAT designation indicates that SENTI-202 has the potential to address unmet medical needs for patients with Relapsed/Refractory (R/R) Acute ...

This study retrospectively analyzed ten pediatric patients with HOX-driven AML who received revumenib maintenance after HSCT at a single-center. The median age was 10 years (range: 1-18). 80% (8/10) ...

Please provide your email address to receive an email when new articles are posted on . Healio spoke with Nikki Yuill, LCSW, and Michelle Rajotte, LMSW, the director and associate director of The ...

The global acute lymphocytic leukemia (ALL) market is set for substantial growth from 2025 to 2035, fueled by advances in chemotherapy, targeted therapies, and immunotherapy. Particularly affecting ...